Atherosclerosis in Apolipoprotein E-knockout Mice as a Model of Human Disease

Editorial

Austin J Cardiovasc Dis Atherosclerosis. 2015; 2(1): 1011.

Atherosclerosis in Apolipoprotein E-knockout Mice as a Model of Human Disease

Shibata MA¹*, Shibata E², Fujioka S¹ and Harada- Shiba M²

¹Department of Anatomy & Histopathology, Graduate School of Health Sciences, Osaka Health Science University, Japan

²Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute, Japan

*Corresponding author: Masa-Aki Shibata, Department of Anatomy & Histopathology, Graduate School of Health Sciences, Osaka Health Science University, 1-9-27, Temma, Kita-ku, Osaka, 530-0043, Japan

Received: September 07, 2015; Accepted: September 22, 2015; Published: September 25, 2015

Editorial

Cardiovascular disease was the top cause of death in the world in 2000 and 2012 according to the World Health Organization fact sheet [1]. In 2012, an estimated 56 million people died worldwide, with cardiovascular diseases responsible for 17.5 million of those deaths; this translates to 3 in every 10 fatalities. Ischemic heart disease alone killed 7.4 million people [1]. In Japan, vascular disease of the heart and of the brain are the 2nd and 4th most common cause of death, respectively, according to the 2012 annual report of the Ministry of Health, Labour and Welfare [2]. When considered together, they come close to malignant neoplasm as the most lethal disease of man. The primary etiologic lesion of cardiovascular disease is atherosclerosis, which causes vessel stenosis, embolus via thrombus formation, and ischemia of heart and brain.

Establishment and availability of a relevant atherosclerotic animal model is an extremely crucial tool in translational research to study and understand the disease process. A gene-targeted mouse model of atherosclerosis was created by the Jackson Laboratory in Bar Harbor, Maine, USA; C57BL/6J mice homozygous for the ApoEtm1Unc mutation results in functional knockout of the anti-atherogenic apolipoprotein E (ApoE) gene involved in cholesterol metabolism [3,4]. This ApoEknockout (ApoE-KO) mouse has been and remains to be the most popular animal model for atherosclerosis research because of its propensity to spontaneously develop hypercholesterolemia and atherosclerotic lesions that are similar to those found in humans [5,6].

Macroscopic findings of the atherosclerotic lesions developed by ApoE-KO mice are presented in (Figure 1). Atherosclerotic lesions are seen in aortic arch and in the bifurcations of the descending aorta (Figure 1). Histopathological findings of the atherosclerotic lesions are shown in (Figure 2). These lesions were classified into 3 categories: i) Early, ii) Progressive and iii) Combined. Early lesions show fatty streaks which involve foamy cell accumulations (Figure 2A & 2B). Progressive lesions are composed of foamy cell accumulations, a fibrous cap and lipid cores (Figure 2C & 2D). Complicated lesions are characterized by accompanying ossification and/or occlusion of the lumen (Figure 2E-2G).

Citation: Shibata MA, Shibata E, Fujioka S and Harada-Shiba M. Atherosclerosis in Apolipoprotein E-knockout Mice as a Model of Human Disease. Austin J Cardiovasc Dis Atherosclerosis. 2015; 2(1): 1011. ISSN:2472-3568